Global Cancer Diagnostics Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024

SKU ID : DBMR- 10788128

Publishing Date : 01-Jun-2017

No. of pages : 350


  • In this region, Global cancer diagnostics is projected to reach USD 40.10 billion by 2024 from USD 16.55 billion in 2016, at a CAGR of 11.7% in the forecast period 2017 to 2024.
    The major factors driving the growth of this market are the growing aging population worldwide, government initiatives for funding, and awareness about cancer.

    The key market players for Global Cancer Diagnostics Market are listed below:

    • GE Healthcare
    • Siemens Healthcare
    • GmbH
    • Hologic, Inc,
    • Becton,
    • Dickinson and Company
    • Thermo Fisher Scientific, Inc.
    • Illumina, Inc.
    • Roche Diagnostics,
    • Abbott,
    • QIAGEN.
    The market is further segmented into:
    • Type
    • Application
    • Technology
    • End User
    • Geography

    The global cancer diagnostics market is segmented on the basis of technology, application, and geography. The global cancer diagnostics market is segmented into two types, platform based and instrument based. In 2017, the cancer diagnostics instrument based segment is expected to dominate the market with a share of 68.8% and is expected to continue this trend till 2024.
    Cancer diagnostics platform based market is segmented into polymerase chain reaction (PCR), in situ hybridization (ISH), immunohisto chemistry (IHC), next generation sequencing (NGS), DNA microarrays, flow cytometry and others. Cancer Diagnostics instrument based market is segmented into imaging and biopsy. Imaging is further segmented into magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography- computed tomography (PET-CT), mammography, and ultrasound.
    On the basis of application, the market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma and others.
    Based on geography, the Global cancer diagnostics market is segmented into 11 geographical regions, such as,

    • North America,
    • Europe,
    • Asia-Pacific,
    • Latin America,
    • Rest of the World

    Covered in this report
    The report covers the present scenario and the growth prospects of the Global cancer diagnostics market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
    You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.